Erratum: Alzheimer's disease drug development pipeline: 2023
Alzheimer s & Dementia Translational Research & Clinical Interventions · 2023
In the paper by Cummings et al.(Alzheimer's disease drug development pipeline: 2023. Alzheimer's Dement. 2023; 9:e12385. https://doi.org/10.1002/trc2.12385), an error occurred in the preparation of the paper for publication, requiring the following correction. In the initial publication of this article, two authors have incorrect affiliations listed. The correct affiliations are listed below. Kate Zhong is affiliated with affiliation number one: Chambers-Grundy Center for Transformative Neuroscience, Department of Brain Health, School of Integrated Health Sciences, University of Nevada, Las Vegas (UNLV), Las Vegas, Nevada, 89154, USA Jorge Fonseca is affiliated with affiliation number four: Howard R Hughes College of Engineering, Department of Computer Science, University of Nevada, Las Vegas (UNLV), Las Vegas, Nevada, 89154, USA The authors regret the error.